Ernexa Therapeutics Inc. Warrants ( ERNAW) - Key Metrics
ERNAW Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | $0 | -$6.95 | -$2.86 | -$2.86 |
| 2025Q4 | $0 | -$4.78 | -$3.65 | -$3.70 |
| 2025Q3 | $0 | -$3.77 | -$3.87 | -$3.93 |
| 2025Q2 | $0 | -$15.15 | -$12.22 | -$12.22 |
ERNAW Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | 0% | 0.00 |
| 2025Q4 | 0% | -0.01 |
| 2025Q3 | 0% | -0.01 |
| 2025Q2 | 0% | 0.00 |
ERNAW
Price: $0.05
52 week price:
Exchange: NGM
Sector: Financial Services
Industry: Asset Management
Market Capitalization: 343180